[Pe-29] English Poster Session 29 ALS (basic research) 02

[Pe-29-8] Phase 1/2a, Double-blind, Placebo-controlled Study of Ropinirole Hydrochloride for ALS (ROPALS)

^○Shinichi Takahashi^1,2,3, Satoru Morimoto¹, Kensuke Okada², Yugaku Daté², Daisuke Ito², Jin Nakahara², Hideyuki Okano¹ (1.Department of Physiology, Keio University School of Medicine, Japan, 2.Department of Neurology, Keio University School of Medicine, Japan, 3.Department of Neurology and Stroke, Saitama Medical University International Medical Center, Japan)